Keywords
Last Name
Institution

Biree Andemariam MD

TitleAssistant Professor
InstitutionUConn Health Center
DepartmentMedicine
AddressMC 1628
MC 1628
263 Farmington Avenue
Phone860-679-2257
Fax860-679-4451
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionUConn Health Center
    DepartmentNeag Cancer Center
    DivisionLea's Foundation Center for Hematologic Disorders

    TitleAssistant Professor
    InstitutionUConn Health Center
    DepartmentNeag Cancer Center
    DivisionHematology/Oncology

    TitleCICATS K12 Scholar
    InstitutionUConn Health Center
    DepartmentConnecticut Institute for Clinical and Translational Science


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Swede H, Sarwar A, Magge A, Braithwaite D, Cook LS, Gregorio DI, Jones BA, R Hoag J, Gonsalves L, L Salner A, Zarfos K, Andemariam B, Stevens RG, G Dugan A, Pensa M, A Brockmeyer J. Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis. Cancer Causes Control. 2016 May; 27(5):627-36. PMID: 27000206.
      View in: PubMed
    2. Szczepanek SM, Roberts S, Rogers K, Cotte C, Adami AJ, Bracken SJ, Salmon S, Secor ER, Thrall RS, Andemariam B, Metzger DW. Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers. PLoS One. 2016; 11(2):e0149261. PMID: 26910228.
      View in: PubMed
    3. Works T, Jones S, Grady J, Andemariam B. Traumatic Exposure History as a Risk Factor for Chronic Pain in Adult Patients with Sickle Cell Disease. Health Soc Work. 2016 Feb; 41(1):42-50. PMID: 26946885.
      View in: PubMed
    4. Andemariam B, Jones S. Development of a New Adult Sickle Cell Disease Center Within an Academic Cancer Center: Impact on Hospital Utilization Patterns and Care Quality. J Racial Ethn Health Disparities. 2016 Mar; 3(1):176-82. PMID: 26896118.
      View in: PubMed
    5. Vigil GD, Adami AJ, Ahmed T, Khan A, Chapman S, Andemariam B, Thrall RS, Howard SS. Label-free and depth resolved optical sectioning of iron-complex deposits in sickle cell disease splenic tissue by multiphoton microscopy. J Biomed Opt. 2015 Jun; 20(6):066001. PMID: 26042382.
      View in: PubMed
    6. Andemariam B, Adami AJ, Singh A, McNamara JT, Secor ER, Guernsey LA, Thrall RS. The sickle cell mouse lung: proinflammatory and primed for allergic inflammation. Transl Res. 2015 Sep; 166(3):254-68. PMID: 25843670; PMCID: PMC4537824 [Available on 09/01/16].
    7. Maciaszek JL, Partola K, Zhang J, Andemariam B, Lykotrafitis G. Single-cell force spectroscopy as a technique to quantify human red blood cell adhesion to subendothelial laminin. J Biomech. 2014 Dec 18; 47(16):3855-61. PMID: 25458578.
      View in: PubMed
    8. Swede H, Andemariam B, Gregorio DI, Jones BA, Braithwaite D, Rohan TE, Stevens RG. Adverse events in cancer patients with sickle cell trait or disease: case reports. Genet Med. 2015 Mar; 17(3):237-41. PMID: 25144888.
      View in: PubMed
    9. Maciaszek JL, Andemariam B, Abiraman K, Lykotrafitis G. AKAP-dependent modulation of BCAM/Lu adhesion on normal and sickle cell disease RBCs revealed by force nanoscopy. Biophys J. 2014 Mar 18; 106(6):1258-67. PMID: 24655501; PMCID: PMC3984978.
    10. Andemariam B, Owarish-Gross J, Grady J, Boruchov D, Thrall RS, Hagstrom JN. Identification of risk factors for an unsuccessful transition from pediatric to adult sickle cell disease care. Pediatr Blood Cancer. 2014 Apr; 61(4):697-701. PMID: 24347402.
      View in: PubMed
    11. Andemariam B, Browning SL. Current management of sickle cell disease in pregnancy. Clin Lab Med. 2013 Jun; 33(2):293-310. PMID: 23702119.
      View in: PubMed
    12. Szczepanek SM, Secor ER, Bracken SJ, Guernsey L, Rafti E, Matson A, Thrall RS, Andemariam B. Transgenic sickle cell disease mice have high mortality and dysregulated immune responses after vaccination. Pediatr Res. 2013 Aug; 74(2):141-7. PMID: 23728384; PMCID: PMC4487511.
    13. Szczepanek SM, McNamara JT, Secor ER, Natarajan P, Guernsey LA, Miller LA, Ballesteros E, Jellison E, Thrall RS, Andemariam B. Splenic morphological changes are accompanied by altered baseline immunity in a mouse model of sickle-cell disease. Am J Pathol. 2012 Nov; 181(5):1725-34. PMID: 23000264; PMCID: PMC3483810.
    14. Elstrom RL, Andemariam B, Martin P, Ruan J, Shore TB, Coleman M, Leonard JP, Furman RR. Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma. Leuk Lymphoma. 2012 Aug; 53(8):1469-73. PMID: 22263572.
      View in: PubMed
    15. Maciaszek JL, Andemariam B, Huber G, Lykotrafitis G. Epinephrine modulates BCAM/Lu and ICAM-4 expression on the sickle cell trait red blood cell membrane. Biophys J. 2012 Mar 7; 102(5):1137-43. PMID: 22404936; PMCID: PMC3296041.
    16. Peerschke EI, Andemariam B, Yin W, Bussel JB. Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura. Br J Haematol. 2010 Feb; 148(4):638-45. PMID: 19925495.
      View in: PubMed
    17. Rutherford SC, Andemariam B, Philips SM, Elstrom RL, Chadburn A, Furman RR, Niesvizky R, Martin P, Fahey TJ, Coleman M, Goldsmith SJ, Leonard JP. FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma. Leuk Lymphoma. 2008 Apr; 49(4):719-26. PMID: 18398739.
      View in: PubMed
    18. Andemariam B, Bussel J. New therapies for immune thrombocytopenic purpura. Curr Opin Hematol. 2007 Sep; 14(5):427-31. PMID: 17934347.
      View in: PubMed
    19. Andemariam B, Leonard JP. Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin's lymphoma. Biologics. 2007 Jun; 1(2):113-20. PMID: 19707321; PMCID: PMC2721297.
    20. Andemariam B, Psaila B, Bussel JB. Novel thrombopoietic agents. Hematology Am Soc Hematol Educ Program. 2007; 106-13. PMID: 18024617.
      View in: PubMed
    21. Andemariam B, Leonard JP. Should all patients with indolent lymphoma be treated with rituximab maintenance therapy? An overview of the data. Clin Lymphoma Myeloma. 2006 Oct; 7 Suppl 1:S20-3. PMID: 17101069.
      View in: PubMed
    22. Wagner MA, Andemariam B, Desai SA. A two-compartment model of osmotic lysis in Plasmodium falciparum-infected erythrocytes. Biophys J. 2003 Jan; 84(1):116-23. PMID: 12524269; PMCID: PMC1302597.
    23. Jacobs NL, Andemariam B, Underwood KW, Panchalingam K, Sternberg D, Kielian M, Liscum L. Analysis of a Chinese hamster ovary cell mutant with defective mobilization of cholesterol from the plasma membrane to the endoplasmic reticulum. J Lipid Res. 1997 Oct; 38(10):1973-87. PMID: 9374120.
      View in: PubMed
    24. Underwood KW, Andemariam B, McWilliams GL, Liscum L. Quantitative analysis of hydrophobic amine inhibition of intracellular cholesterol transport. J Lipid Res. 1996 Jul; 37(7):1556-68. PMID: 8827526.
      View in: PubMed
    Andemariam's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _